Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
AssayType

Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

14434082 83783 17 None -3 3 Human 4.8 pEC50 = 4.8 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
CHEMBL2205801 83783 17 None -3 3 Human 4.8 pEC50 = 4.8 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
14434082 83783 17 None -3 3 Human 4.8 pEC50 = 4.8 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
CHEMBL2205801 83783 17 None -3 3 Human 4.8 pEC50 = 4.8 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
72791 208240 76 None -1 2 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cc2cccnc2c2ncccc12 10.1021/jm301121j
CHEMBL98682 208240 76 None -1 2 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cc2cccnc2c2ncccc12 10.1021/jm301121j
72791 208240 76 None -1 2 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cc2cccnc2c2ncccc12 10.1021/jm301121j
CHEMBL98682 208240 76 None -1 2 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cc2cccnc2c2ncccc12 10.1021/jm301121j
77865 107286 82 None 1 2 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 214 0 0 2 3.4 Clc1cc2cccnc2c2ncccc12 10.1021/jm301121j
CHEMBL317115 107286 82 None 1 2 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 214 0 0 2 3.4 Clc1cc2cccnc2c2ncccc12 10.1021/jm301121j
14338 4368 124 None 3 3 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
CHEMBL101165 4368 124 None 3 3 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
77865 107286 82 None 1 2 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 214 0 0 2 3.4 Clc1cc2cccnc2c2ncccc12 10.1021/jm301121j
CHEMBL317115 107286 82 None 1 2 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 214 0 0 2 3.4 Clc1cc2cccnc2c2ncccc12 10.1021/jm301121j
14338 4368 124 None 3 3 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
CHEMBL101165 4368 124 None 3 3 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
667748 83786 86 None 3 3 Human 6.4 pEC50 = 6.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
CHEMBL2205805 83786 86 None 3 3 Human 6.4 pEC50 = 6.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
12425 6 126 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 6 126 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 6 126 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 6 126 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
667748 83786 86 None 3 3 Human 6.4 pEC50 = 6.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
CHEMBL2205805 83786 86 None 3 3 Human 6.4 pEC50 = 6.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
12425 6 126 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 6 126 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 6 126 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 6 126 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1474 154399 142 None -1 3 Human 4.4 pEC50 = 4.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 154399 142 None -1 3 Human 4.4 pEC50 = 4.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
1474 154399 142 None -1 3 Human 4.4 pEC50 = 4.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 154399 142 None -1 3 Human 4.4 pEC50 = 4.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
74265 208347 115 None 2 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
CHEMBL99384 208347 115 None 2 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
20445 83787 115 None 2 2 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1cccc(-c2cccc(C)n2)n1 10.1021/jm301121j
CHEMBL2205806 83787 115 None 2 2 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1cccc(-c2cccc(C)n2)n1 10.1021/jm301121j
70848 206672 112 None 5 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 206672 112 None 5 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
72792 199723 84 None 5 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
CHEMBL593442 199723 84 None 5 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
74265 208347 115 None 2 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
CHEMBL99384 208347 115 None 2 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
20445 83787 115 None 2 2 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1cccc(-c2cccc(C)n2)n1 10.1021/jm301121j
CHEMBL2205806 83787 115 None 2 2 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1cccc(-c2cccc(C)n2)n1 10.1021/jm301121j
2733927 83789 97 None 1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
CHEMBL2205808 83789 97 None 1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
70848 206672 112 None 5 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 206672 112 None 5 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
72792 199723 84 None 5 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
CHEMBL593442 199723 84 None 5 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
2733927 83789 97 None 1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
CHEMBL2205808 83789 97 None 1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
15783796 83792 1 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
CHEMBL2205810 83792 1 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
93149 107201 84 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 107201 84 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
12987698 83790 4 None -3 3 Human 5.2 pEC50 = 5.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
CHEMBL2205809 83790 4 None -3 3 Human 5.2 pEC50 = 5.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
15783796 83792 1 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
CHEMBL2205810 83792 1 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
93149 107201 84 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 107201 84 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
12987698 83790 4 None -3 3 Human 5.2 pEC50 = 5.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
CHEMBL2205809 83790 4 None -3 3 Human 5.2 pEC50 = 5.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
15664 83788 101 None -2 3 Human 5.1 pEC50 = 5.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
CHEMBL2205807 83788 101 None -2 3 Human 5.1 pEC50 = 5.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
15664 83788 101 None -2 3 Human 5.1 pEC50 = 5.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
CHEMBL2205807 83788 101 None -2 3 Human 5.1 pEC50 = 5.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
77524 55887 100 None - 1 Human 4.1 pEC50 = 4.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 212 0 2 4 2.2 Oc1ccnc2c1ccc1c(O)ccnc12 10.1021/jm301121j
CHEMBL1623498 55887 100 None - 1 Human 4.1 pEC50 = 4.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 212 0 2 4 2.2 Oc1ccnc2c1ccc1c(O)ccnc12 10.1021/jm301121j
77524 55887 100 None - 1 Human 4.1 pEC50 = 4.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 212 0 2 4 2.2 Oc1ccnc2c1ccc1c(O)ccnc12 10.1021/jm301121j
CHEMBL1623498 55887 100 None - 1 Human 4.1 pEC50 = 4.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 212 0 2 4 2.2 Oc1ccnc2c1ccc1c(O)ccnc12 10.1021/jm301121j
10391001 137198 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374939 137198 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
11541506 76516 0 None - 1 Human 9.0 pIC50 = 9 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 575 9 2 5 5.7 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)C1 10.1021/jm050965z
CHEMBL205993 76516 0 None - 1 Human 9.0 pIC50 = 9 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 575 9 2 5 5.7 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)C1 10.1021/jm050965z
16105860 137203 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 507 8 2 4 4.7 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(CC)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374978 137203 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 507 8 2 4 4.7 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(CC)cc3)c3ccccc23)CC1 10.1021/jm061118e
16105782 82705 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 482 6 2 6 3.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccncc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL217965 82705 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 482 6 2 6 3.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccncc3)c3ccccc23)CC1 10.1021/jm061118e
16112836 93365 2 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human recombinant CCR8 expressed in Th2 cells assessed as I309 mediated migration by chemotaxis assayAntagonist activity at human recombinant CCR8 expressed in Th2 cells assessed as I309 mediated migration by chemotaxis assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL245568 93365 2 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human recombinant CCR8 expressed in Th2 cells assessed as I309 mediated migration by chemotaxis assayAntagonist activity at human recombinant CCR8 expressed in Th2 cells assessed as I309 mediated migration by chemotaxis assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439843 91540 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 426 4 1 4 4.9 O=C1OC(c2ccnc3ccccc23)CN1C1CCN(Cc2cc3ccccc3[nH]2)CC1 10.1016/j.bmcl.2006.12.076
CHEMBL240462 91540 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 426 4 1 4 4.9 O=C1OC(c2ccnc3ccccc23)CN1C1CCN(Cc2cc3ccccc3[nH]2)CC1 10.1016/j.bmcl.2006.12.076
16105780 84601 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 481 7 2 6 3.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cnccn3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL222112 84601 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 481 7 2 6 3.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cnccn3)c3ccccc23)CC1 10.1021/jm061118e
44598057 197070 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 421 6 0 4 4.6 CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
CHEMBL567419 197070 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 421 6 0 4 4.6 CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
11533398 75986 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 499 8 2 5 4.9 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)CC2)c1 10.1021/jm050965z
CHEMBL205447 75986 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 499 8 2 5 4.9 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)CC2)c1 10.1021/jm050965z
44457090 97662 1 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
CHEMBL271128 97662 1 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
11950828 97621 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2 10.1021/jm070543k
CHEMBL270971 97621 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2 10.1021/jm070543k
11950828 97621 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2 10.1021/jm900713y
CHEMBL270971 97621 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2 10.1021/jm900713y
44457090 97662 1 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm070543k
CHEMBL271128 97662 1 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm070543k
44457009 159008 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccc(Cl)cc2)CC3)c1 10.1021/jm070543k
CHEMBL409648 159008 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccc(Cl)cc2)CC3)c1 10.1021/jm070543k
16105857 166202 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 479 7 2 4 4.2 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL426551 166202 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 479 7 2 4 4.2 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
10480554 150215 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 485 5 0 5 5.7 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Cl)c(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL395211 150215 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 485 5 0 5 5.7 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Cl)c(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439881 93800 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 457 5 0 6 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6o5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247563 93800 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 457 5 0 6 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6o5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
10004785 93844 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 467 5 0 5 5.6 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc6ccccc6c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247762 93844 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 467 5 0 5 5.6 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc6ccccc6c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439890 93915 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 447 6 0 6 4.4 COc1ccc(CN2CCC(N3CC(c4ccnc5ccc(OC)cc45)OC3=O)CC2)cc1 10.1016/j.bmcl.2006.12.076
CHEMBL248171 93915 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 447 6 0 6 4.4 COc1ccc(CN2CCC(N3CC(c4ccnc5ccc(OC)cc45)OC3=O)CC2)cc1 10.1016/j.bmcl.2006.12.076
44439886 93876 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 417 5 0 5 4.4 COc1ccc2nccc(C3CN(C4CCN(Cc5ccccc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247964 93876 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 417 5 0 5 4.4 COc1ccc2nccc(C3CN(C4CCN(Cc5ccccc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439895 150466 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 442 5 0 6 4.3 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(C#N)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL395423 150466 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 442 5 0 6 4.3 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(C#N)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
16065425 197228 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 405 3 0 4 3.9 CC1Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)c2O1 10.1021/jm900713y
CHEMBL568296 197228 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 405 3 0 4 3.9 CC1Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)c2O1 10.1021/jm900713y
16105885 82773 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 580 11 2 6 5.0 CCN(CC)CCCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL217984 82773 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 580 11 2 6 5.0 CCN(CC)CCCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
44598821 197938 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 472 6 0 6 4.8 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2 10.1021/jm900713y
CHEMBL573216 197938 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 472 6 0 6 4.8 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2 10.1021/jm900713y
44598059 197012 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm900713y
CHEMBL566974 197012 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm900713y
44598769 197099 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 422 6 0 5 4.0 CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2 10.1021/jm900713y
CHEMBL567620 197099 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 422 6 0 5 4.0 CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2 10.1021/jm900713y
16105854 83912 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 485 8 2 4 4.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)CC3CCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220650 83912 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 485 8 2 4 4.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)CC3CCCC3)c3ccccc23)CC1 10.1021/jm061118e
16065428 197858 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 391 3 0 4 3.5 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc4c3OCC4)CC2)CC1 10.1021/jm900713y
CHEMBL572537 197858 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 391 3 0 4 3.5 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc4c3OCC4)CC2)CC1 10.1021/jm900713y
16105774 84324 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 10 2 4 5.5 CCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCN(C(=O)CCC)CC3)c3ccccc23)cc1 10.1021/jm061118e
CHEMBL221601 84324 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 10 2 4 5.5 CCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCN(C(=O)CCC)CC3)c3ccccc23)cc1 10.1021/jm061118e
3384970 161281 8 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 432 6 2 4 4.9 COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)cc1 10.1021/jm061118e
CHEMBL412116 161281 8 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 432 6 2 4 4.9 COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)cc1 10.1021/jm061118e
16105862 83389 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 469 7 2 5 3.8 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccoc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL219432 83389 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 469 7 2 5 3.8 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccoc3)c3ccccc23)CC1 10.1021/jm061118e
44439837 147977 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 430 8 2 5 4.4 COc1ccc2nccc(C3CN(CCCNCc4cc5ccccc5[nH]4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL393411 147977 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 430 8 2 5 4.4 COc1ccc2nccc(C3CN(CCCNCc4cc5ccccc5[nH]4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44457089 97661 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccccn1)CC2 10.1021/jm070543k
CHEMBL271127 97661 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccccn1)CC2 10.1021/jm070543k
11950826 159189 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 457 5 0 4 4.6 O=C(c1cc[n+]([O-])cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
CHEMBL409849 159189 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 457 5 0 4 4.6 O=C(c1cc[n+]([O-])cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
44456993 97787 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
CHEMBL271801 97787 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
44456993 97787 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
CHEMBL271801 97787 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
44598060 197266 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 0 5 4.1 CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccncn3)CC4)ccc2O1 10.1021/jm900713y
CHEMBL568503 197266 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 0 5 4.1 CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccncn3)CC4)ccc2O1 10.1021/jm900713y
44457046 167335 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
CHEMBL429436 167335 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
44457046 167335 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
CHEMBL429436 167335 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
16105772 83373 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3F)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL219380 83373 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3F)c3ccccc23)CC1 10.1021/jm061118e
16105819 84490 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 622 9 2 7 4.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CC(C)OC(C)C3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL222020 84490 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 622 9 2 7 4.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CC(C)OC(C)C3)CC2)c2ccccc12 10.1021/jm061118e
16112836 93365 2 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL245568 93365 2 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
45483901 197069 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 476 6 1 5 5.1 CCCC1(CC)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL567417 197069 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 476 6 1 5 5.1 CCCC1(CC)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
16064872 197271 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)c2O1 10.1021/jm900713y
CHEMBL568523 197271 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)c2O1 10.1021/jm900713y
44598124 198638 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 470 3 1 5 4.4 CC1(C)Oc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2C1(F)F 10.1021/jm900713y
CHEMBL579072 198638 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 470 3 1 5 4.4 CC1(C)Oc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2C1(F)F 10.1021/jm900713y
45483880 197227 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 476 3 1 5 4.9 CC(C)(C)C1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL568294 197227 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 476 3 1 5 4.9 CC(C)(C)C1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
16105859 84329 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccc(F)c3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221639 84329 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccc(F)c3)c3ccccc23)CC1 10.1021/jm061118e
16105864 84364 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 483 7 2 6 2.9 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3nccn3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221842 84364 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 483 7 2 6 2.9 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3nccn3C)c3ccccc23)CC1 10.1021/jm061118e
16105855 83143 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 487 7 2 5 3.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCOCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218209 83143 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 487 7 2 5 3.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCOCC3)c3ccccc23)CC1 10.1021/jm061118e
11584004 140698 1 None - 1 Human 7.7 pIC50 = 7.7 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 489 7 2 4 5.1 O=C(NC1CCN(Cc2cccc(Oc3ccccc3Cl)c2)CC1)C1(c2ccccc2)CCNC1 10.1021/jm050965z
CHEMBL381619 140698 1 None - 1 Human 7.7 pIC50 = 7.7 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 489 7 2 4 5.1 O=C(NC1CCN(Cc2cccc(Oc3ccccc3Cl)c2)CC1)C1(c2ccccc2)CCNC1 10.1021/jm050965z
45483913 196929 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ncccc3N)CC4)c2O1 10.1021/jm900713y
CHEMBL566324 196929 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ncccc3N)CC4)c2O1 10.1021/jm900713y
44598121 197100 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL567627 197100 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)cccc2O1 10.1021/jm900713y
16105777 136959 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 7 2 5 5.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc4ccccc4s3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374414 136959 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 7 2 5 5.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc4ccccc4s3)c3ccccc23)CC1 10.1021/jm061118e
16105776 136935 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 585 10 2 5 5.7 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(OCc4ccccc4)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374274 136935 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 585 10 2 5 5.7 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(OCc4ccccc4)cc3)c3ccccc23)CC1 10.1021/jm061118e
9911916 91679 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL240848 91679 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
10433657 93877 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 445 7 0 5 4.8 COc1ccc2nccc(C3CN(C4CCN(CCCc5ccccc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247965 93877 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 445 7 0 5 4.8 COc1ccc2nccc(C3CN(C4CCN(CCCc5ccccc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
11842667 161046 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cccc[n+]2[O-])CC3)c1 10.1021/jm070543k
CHEMBL411651 161046 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cccc[n+]2[O-])CC3)c1 10.1021/jm070543k
44456948 160117 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
CHEMBL410885 160117 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
44456948 160117 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
CHEMBL410885 160117 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
16105887 84347 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 640 9 2 6 5.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CCc4ccccc4C3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221712 84347 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 640 9 2 6 5.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CCc4ccccc4C3)CC2)c2ccccc12 10.1021/jm061118e
16105865 169341 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 494 7 2 5 3.9 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccnc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL441870 169341 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 494 7 2 5 3.9 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccnc3C)c3ccccc23)CC1 10.1021/jm061118e
16065567 198826 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 419 3 0 4 4.3 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL583621 198826 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 419 3 0 4 4.3 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)cccc2O1 10.1021/jm900713y
10479253 91539 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 457 5 1 6 4.3 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2n1 10.1016/j.bmcl.2006.12.076
CHEMBL240461 91539 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 457 5 1 6 4.3 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2n1 10.1016/j.bmcl.2006.12.076
44439883 93843 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 468 5 0 6 5.0 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc6ccccc6n5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247761 93843 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 468 5 0 6 5.0 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc6ccccc6n5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
10412437 151329 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 470 5 0 6 4.9 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6n5C)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL396102 151329 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 470 5 0 6 4.9 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6n5C)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
11951000 97822 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1 10.1021/jm900713y
CHEMBL272022 97822 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1 10.1021/jm900713y
44457093 97778 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm070543k
CHEMBL271768 97778 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm070543k
11951000 97822 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1 10.1021/jm070543k
CHEMBL272022 97822 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1 10.1021/jm070543k
44457105 158614 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2 10.1021/jm070543k
CHEMBL409224 158614 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2 10.1021/jm070543k
44457105 158614 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2 10.1021/jm900713y
CHEMBL409224 158614 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2 10.1021/jm900713y
16105775 83388 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 549 11 2 4 5.9 CCCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCN(C(=O)CCC)CC3)c3ccccc23)cc1 10.1021/jm061118e
CHEMBL219431 83388 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 549 11 2 4 5.9 CCCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCN(C(=O)CCC)CC3)c3ccccc23)cc1 10.1021/jm061118e
16105868 138041 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 471 7 2 4 4.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL376517 138041 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 471 7 2 4 4.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCCC3)c3ccccc23)CC1 10.1021/jm061118e
16105867 137866 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 443 7 2 4 3.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL376071 137866 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 443 7 2 4 3.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CC3)c3ccccc23)CC1 10.1021/jm061118e
16105863 84331 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 539 7 2 6 4.2 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C(C)(C)C)nn3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221650 84331 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 539 7 2 6 4.2 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C(C)(C)C)nn3C)c3ccccc23)CC1 10.1021/jm061118e
10003657 152830 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 445 5 0 5 5.0 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(C)c(C)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL397395 152830 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 445 5 0 5 5.0 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(C)c(C)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
11685733 140202 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 589 9 2 5 6.1 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL380492 140202 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 589 9 2 5 6.1 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105817 136972 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 578 9 2 6 4.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL374527 136972 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 578 9 2 6 4.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
44598058 198132 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 472 6 0 6 4.8 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccncn2)CC3)c1 10.1021/jm900713y
CHEMBL574655 198132 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 472 6 0 6 4.8 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccncn2)CC3)c1 10.1021/jm900713y
16105781 83160 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 480 7 2 5 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccn3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218298 83160 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 480 7 2 5 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccn3)c3ccccc23)CC1 10.1021/jm061118e
11526626 75542 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 531 8 1 4 6.3 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL204419 75542 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 531 8 1 4 6.3 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105779 137201 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 528 7 2 5 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C)nc(Cl)c3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374964 137201 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 528 7 2 5 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C)nc(Cl)c3)c3ccccc23)CC1 10.1021/jm061118e
16105778 82597 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 551 7 2 5 5.1 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C)oc3C(F)(F)F)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL217909 82597 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 551 7 2 5 5.1 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C)oc3C(F)(F)F)c3ccccc23)CC1 10.1021/jm061118e
16105858 84360 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccc(C)c3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221790 84360 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccc(C)c3)c3ccccc23)CC1 10.1021/jm061118e
44598062 197270 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 446 3 1 5 4.4 CC1(C)C=Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1 10.1021/jm900713y
CHEMBL568522 197270 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 446 3 1 5 4.4 CC1(C)C=Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1 10.1021/jm900713y
10255258 150468 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 495 5 0 5 5.2 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Br)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL395424 150468 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 495 5 0 5 5.2 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Br)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
16112836 93365 2 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR8 expressed in HUT78 cells assessed as I309-mediated migration by chemotaxis assayAntagonist activity at human recombinant CCR8 expressed in HUT78 cells assessed as I309-mediated migration by chemotaxis assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL245568 93365 2 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR8 expressed in HUT78 cells assessed as I309-mediated migration by chemotaxis assayAntagonist activity at human recombinant CCR8 expressed in HUT78 cells assessed as I309-mediated migration by chemotaxis assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
10409369 169505 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 411 8 0 5 4.8 CCCCCCN1CCC(N2CC(c3ccnc4ccc(OC)cc34)OC2=O)CC1 10.1016/j.bmcl.2006.12.076
CHEMBL443315 169505 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 411 8 0 5 4.8 CCCCCCN1CCC(N2CC(c3ccnc4ccc(OC)cc34)OC2=O)CC1 10.1016/j.bmcl.2006.12.076
44598820 198781 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 465 6 0 4 4.8 O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3OC(F)(F)C(F)F)CC2)CC1 10.1021/jm900713y
CHEMBL583212 198781 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 465 6 0 4 4.8 O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3OC(F)(F)C(F)F)CC2)CC1 10.1021/jm900713y
11965686 198855 2 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 1 5 4.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc[nH]c1=O)CC2 10.1021/jm900713y
CHEMBL583843 198855 2 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 1 5 4.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc[nH]c1=O)CC2 10.1021/jm900713y
11539239 78126 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 430 8 1 4 4.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)Cc3ccccc3)CC2)c1 10.1021/jm050965z
CHEMBL210322 78126 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 430 8 1 4 4.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)Cc3ccccc3)CC2)c1 10.1021/jm050965z
11519336 77876 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 527 9 1 5 5.6 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4OC)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL209350 77876 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 527 9 1 5 5.6 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4OC)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105783 83211 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 457 7 2 4 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218554 83211 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 457 7 2 4 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCC3)c3ccccc23)CC1 10.1021/jm061118e
16105773 84410 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(F)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221978 84410 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(F)cc3)c3ccccc23)CC1 10.1021/jm061118e
16105784 84320 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 485 7 2 4 4.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221586 84320 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 485 7 2 4 4.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
16065704 198873 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 436 3 1 6 3.7 CC1(C)Oc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1 10.1021/jm900713y
CHEMBL584087 198873 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 436 3 1 6 3.7 CC1(C)Oc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1 10.1021/jm900713y
16105861 83159 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 7 2 4 5.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(C(C)(C)C)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218297 83159 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 7 2 4 5.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(C(C)(C)C)cc3)c3ccccc23)CC1 10.1021/jm061118e
16105787 83913 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 473 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)CC(C)(C)C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220651 83913 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 473 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)CC(C)(C)C)c3ccccc23)CC1 10.1021/jm061118e
10343818 151358 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 451 5 0 5 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Cl)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL396124 151358 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 451 5 0 5 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Cl)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439838 91363 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 444 8 1 5 4.7 COc1ccc2nccc(C3CN(CCCN(C)Cc4cc5ccccc5[nH]4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL240249 91363 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 444 8 1 5 4.7 COc1ccc2nccc(C3CN(CCCN(C)Cc4cc5ccccc5[nH]4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439887 93914 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 451 5 0 5 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5cccc(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL248169 93914 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 451 5 0 5 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5cccc(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439909 167529 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 499 4 0 5 5.3 COc1ccc2nccc(C3CN(C4CCN(C(=O)c5ccc(Cl)c(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL430012 167529 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 499 4 0 5 5.3 COc1ccc2nccc(C3CN(C4CCN(C(=O)c5ccc(Cl)c(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
16105786 141707 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 473 9 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C(CC)CC)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL385654 141707 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 473 9 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C(CC)CC)c3ccccc23)CC1 10.1021/jm061118e
16105856 83914 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 521 9 2 4 5.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C(CC)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220652 83914 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 521 9 2 4 5.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C(CC)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
44598819 196992 1 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 419 6 0 4 4.6 C=C(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
CHEMBL566759 196992 1 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 419 6 0 4 4.6 C=C(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
11950827 97620 2 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cccc[n+]1[O-])CC2 10.1021/jm070543k
CHEMBL270969 97620 2 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cccc[n+]1[O-])CC2 10.1021/jm070543k
10412573 93801 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 473 5 0 6 5.6 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6s5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247564 93801 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 473 5 0 6 5.6 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6s5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439885 93875 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 423 5 0 5 4.8 COc1ccc2nccc(C3CN(C4CCN(CC5CCCCC5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247963 93875 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 423 5 0 5 4.8 COc1ccc2nccc(C3CN(C4CCN(CC5CCCCC5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
16065569 196967 25 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL566543 196967 25 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
11273324 95908 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm070543k
CHEMBL259243 95908 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm070543k
11273324 95908 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm900713y
CHEMBL259243 95908 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm900713y
16105866 83212 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 480 7 2 5 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccnc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218555 83212 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 480 7 2 5 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccnc3)c3ccccc23)CC1 10.1021/jm061118e
16105771 84558 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(C)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL222062 84558 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(C)cc3)c3ccccc23)CC1 10.1021/jm061118e
16105815 83178 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 552 9 2 6 4.2 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN(C)C)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218369 83178 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 552 9 2 6 4.2 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN(C)C)CC2)c2ccccc12 10.1021/jm061118e
44598061 197038 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 448 3 1 5 4.3 CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)ccc2O1 10.1021/jm900713y
CHEMBL567202 197038 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 448 3 1 5 4.3 CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)ccc2O1 10.1021/jm900713y
15664 83788 101 None -2 3 Human 8.3 pEC50 = 8.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
Drug Central 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 None
CHEMBL2205807 83788 101 None -2 3 Human 8.3 pEC50 = 8.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
Drug Central 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 None
486830 4002 0 None -10 5 Human 8.1 pIC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
768 4002 0 None -10 5 Human 8.1 pIC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
812 823 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
812 823 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11154210
812 823 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16221874
815 4001 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
815 4001 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11154210
816 4000 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
11688990 4147 0 None - 1 Human 5.7 pIC50 None 5.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 356 9 1 5 2.6 OCCOCCN1CCN(CC1)Cc1cccc(c1)Oc1ccccc1 16221874
813 4147 0 None - 1 Human 5.7 pIC50 None 5.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 356 9 1 5 2.6 OCCOCCN1CCN(CC1)Cc1cccc(c1)Oc1ccccc1 16221874
CHEMBL1883966 4147 0 None - 1 Human 5.7 pIC50 None 5.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 356 9 1 5 2.6 OCCOCCN1CCN(CC1)Cc1cccc(c1)Oc1ccccc1 16221874




Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Similar-
ity
Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
Assay
Type
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

91032188 193544 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition of CCR8 mutant (unknown origin)Inhibition of CCR8 mutant (unknown origin)
ChEMBL 471 8 1 5 4.5 COc1ccccc1Oc1cccc(CN2CCC3(CC2)C(=O)NCN3CCc2ccccc2)c1 10.1021/acs.jmedchem.6b01309
CHEMBL5268017 193544 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition of CCR8 mutant (unknown origin)Inhibition of CCR8 mutant (unknown origin)
ChEMBL 471 8 1 5 4.5 COc1ccccc1Oc1cccc(CN2CCC3(CC2)C(=O)NCN3CCc2ccccc2)c1 10.1021/acs.jmedchem.6b01309
CHEMBL5277802 193950 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition of CCR8 mutant (unknown origin)Inhibition of CCR8 mutant (unknown origin)
ChEMBL 527 11 1 5 5.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C(CCN3CCCC3)c3ccccc3)CC2)c1 10.1021/acs.jmedchem.6b01309
CHEMBL5272687 193732 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of CCR8 mutant (unknown origin)Inhibition of CCR8 mutant (unknown origin)
ChEMBL 526 10 2 7 4.3 CCNS(=O)(=O)c1ccc(OC)cc1C1(O)CCN(Cc2cccc(Oc3ccccc3OC)c2)CC1 10.1021/acs.jmedchem.6b01309
CHEMBL5270110 193619 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of CCR8 mutant (unknown origin)Inhibition of CCR8 mutant (unknown origin)
ChEMBL 433 7 2 5 4.7 COc1ccccc1Oc1cccc(CN2CCC(O)(c3ccccc3C(=O)O)CC2)c1 10.1021/acs.jmedchem.6b01309
CHEMBL5273480 193767 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of CCR8 mutant (unknown origin)Inhibition of CCR8 mutant (unknown origin)
ChEMBL 485 7 2 5 4.7 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3CC(=O)Nc4ccccc43)CC2)c1 10.1021/acs.jmedchem.6b01309
155557362 174643 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at human CCR8 expressed in CHOK1 cells assessed as reduction in CCL1-induced beta-arrestin 2 recruitment incubated for 30 mins followed by CCL1 addition and measured after 90 or 180 mins by pathhunter beta-arrestin assayAntagonist activity at human CCR8 expressed in CHOK1 cells assessed as reduction in CCL1-induced beta-arrestin 2 recruitment incubated for 30 mins followed by CCL1 addition and measured after 90 or 180 mins by pathhunter beta-arrestin assay
ChEMBL 560 6 1 6 5.4 CC[C@]12C=C(C(=O)OC)n3c(c(CCNC(=O)c4ccc(Br)cc4)c4ccccc43)[C@H]1N(C#N)CCC2 10.1021/acs.jmedchem.9b01924
CHEMBL4558185 174643 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at human CCR8 expressed in CHOK1 cells assessed as reduction in CCL1-induced beta-arrestin 2 recruitment incubated for 30 mins followed by CCL1 addition and measured after 90 or 180 mins by pathhunter beta-arrestin assayAntagonist activity at human CCR8 expressed in CHOK1 cells assessed as reduction in CCL1-induced beta-arrestin 2 recruitment incubated for 30 mins followed by CCL1 addition and measured after 90 or 180 mins by pathhunter beta-arrestin assay
ChEMBL 560 6 1 6 5.4 CC[C@]12C=C(C(=O)OC)n3c(c(CCNC(=O)c4ccc(Br)cc4)c4ccccc43)[C@H]1N(C#N)CCC2 10.1021/acs.jmedchem.9b01924
132072454 179724 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at human CCR8 expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human CCR8 expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 558 6 2 8 4.7 COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN(C#N)[C@H](c3[nH]c4ccccc4c3CCn3cc(-c4cccc(Cl)c4)nn3)C[C@@H]21 10.1016/j.bmc.2020.115546
CHEMBL4744046 179724 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at human CCR8 expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human CCR8 expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 558 6 2 8 4.7 COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN(C#N)[C@H](c3[nH]c4ccccc4c3CCn3cc(-c4cccc(Cl)c4)nn3)C[C@@H]21 10.1016/j.bmc.2020.115546
10367938 83179 0 None - 1 Human 9.8 pKi = 9.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218374 83179 0 None - 1 Human 9.8 pKi = 9.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
10391001 137198 0 None - 1 Human 9.5 pKi = 9.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374939 137198 0 None - 1 Human 9.5 pKi = 9.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
11754900 84366 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 480 5 3 4 3.5 CNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221865 84366 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 480 5 3 4 3.5 CNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
10006907 141814 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 6 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)[C@@H]3CCCN3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL386308 141814 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 6 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)[C@@H]3CCCN3)CC2)c2ccccc12 10.1021/jm061118e
10006907 141814 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 6 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)[C@@H]3CCCN3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL386308 141814 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 6 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)[C@@H]3CCCN3)CC2)c2ccccc12 10.1021/jm061118e
9984180 136549 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 5 2 4 4.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL373739 136549 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 5 2 4 4.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
16105811 137669 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 506 6 3 5 2.9 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CNC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL375854 137669 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 506 6 3 5 2.9 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CNC3)CC2)c2ccccc12 10.1021/jm061118e
16105788 83180 9 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 6 2 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218375 83180 9 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 6 2 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105880 84368 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 8 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCN)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221867 84368 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 8 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCN)CC2)c2ccccc12 10.1021/jm061118e
16105822 138159 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 5 2 4 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N(C)C)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL376910 138159 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 5 2 4 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N(C)C)CC2)c2ccccc12 10.1021/jm061118e
16105890 141946 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 542 6 3 4 5.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)Nc3ccccc3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL387161 141946 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 542 6 3 4 5.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)Nc3ccccc3)CC2)c2ccccc12 10.1021/jm061118e
11519336 77876 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 527 9 1 5 5.6 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4OC)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL209350 77876 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 527 9 1 5 5.6 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4OC)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105807 83972 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 7 3 5 3.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCN)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL220703 83972 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 7 3 5 3.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCN)CC2)c2ccccc12 10.1021/jm061118e
16105813 84245 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 570 7 2 5 5.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)c3ccc(N(C)C)cc3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221078 84245 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 570 7 2 5 5.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)c3ccc(N(C)C)cc3)CC2)c2ccccc12 10.1021/jm061118e
16105831 83414 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 488 5 2 5 3.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)N3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL219589 83414 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 488 5 2 5 3.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)N3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
11502217 76035 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 400 7 1 3 4.8 O=C(Cc1ccccc1)NC1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
CHEMBL205692 76035 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 400 7 1 3 4.8 O=C(Cc1ccccc1)NC1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
11526626 75542 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 531 8 1 4 6.3 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL204419 75542 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 531 8 1 4 6.3 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105760 137867 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 509 5 2 5 4.8 CC(C)(C)OC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL376076 137867 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 509 5 2 5 4.8 CC(C)(C)OC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
16105805 84404 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 7 2 5 3.3 COCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221961 84404 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 7 2 5 3.3 COCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105799 166146 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 482 6 1 6 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(OC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL426207 166146 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 482 6 1 6 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(OC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
11774008 84599 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 402 5 2 3 4.9 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL222110 84599 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 402 5 2 3 4.9 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
16105809 84328 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 522 9 3 5 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCCN)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221638 84328 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 522 9 3 5 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCCN)CC2)c2ccccc12 10.1021/jm061118e
16105889 83971 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 6 3 4 3.9 CCNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220701 83971 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 6 3 4 3.9 CCNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
9982672 82825 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2cccc3c(NC(=O)c4ccccc4)cccc23)CC1 10.1021/jm061118e
CHEMBL218037 82825 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2cccc3c(NC(=O)c4ccccc4)cccc23)CC1 10.1021/jm061118e
16105802 84065 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 479 6 2 4 4.1 CCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220753 84065 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 479 6 2 4 4.1 CCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105895 141918 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc3cccc(NC(=O)c4ccccc4)c3c2)CC1 10.1021/jm061118e
CHEMBL386987 141918 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc3cccc(NC(=O)c4ccccc4)c3c2)CC1 10.1021/jm061118e
11563243 168700 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 575 9 2 5 5.7 CCN1CCC(C(=O)NC2(C(=O)O)CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL436753 168700 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 575 9 2 5 5.7 CCN1CCC(C(=O)NC2(C(=O)O)CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
11270007 84600 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 416 6 2 3 4.6 O=C(Nc1ccc(S(=O)(=O)NCc2ccccc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL222111 84600 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 416 6 2 3 4.6 O=C(Nc1ccc(S(=O)(=O)NCc2ccccc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
16105888 136374 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 466 5 3 4 3.2 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(N)=O)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL373504 136374 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 466 5 3 4 3.2 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(N)=O)CC2)c2ccccc12 10.1021/jm061118e
11541073 75990 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 532 8 1 4 7.1 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccc(Cl)cc4)CCCCC3)CC2)c1 10.1021/jm050965z
CHEMBL205457 75990 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 532 8 1 4 7.1 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccc(Cl)cc4)CCCCC3)CC2)c1 10.1021/jm050965z
11539239 78126 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 430 8 1 4 4.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)Cc3ccccc3)CC2)c1 10.1021/jm050965z
CHEMBL210322 78126 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 430 8 1 4 4.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)Cc3ccccc3)CC2)c1 10.1021/jm050965z
792361 76191 7 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 339 6 0 4 4.3 CCOC(=O)C1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
CHEMBL205808 76191 7 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 339 6 0 4 4.3 CCOC(=O)C1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
11584004 140698 1 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 489 7 2 4 5.1 O=C(NC1CCN(Cc2cccc(Oc3ccccc3Cl)c2)CC1)C1(c2ccccc2)CCNC1 10.1021/jm050965z
CHEMBL381619 140698 1 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 489 7 2 4 5.1 O=C(NC1CCN(Cc2cccc(Oc3ccccc3Cl)c2)CC1)C1(c2ccccc2)CCNC1 10.1021/jm050965z
16105891 84251 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 506 5 2 4 4.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221130 84251 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 506 5 2 4 4.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCC3)CC2)c2ccccc12 10.1021/jm061118e
44419035 84281 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 9 2 5 4.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCCCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221345 84281 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 9 2 5 4.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCCCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
11384528 141632 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 417 6 2 4 4.0 O=C(Nc1ccc(S(=O)(=O)NCc2ccncc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL385287 141632 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 417 6 2 4 4.0 O=C(Nc1ccc(S(=O)(=O)NCc2ccncc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
16105832 83361 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 479 7 2 4 4.1 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)C1 10.1021/jm061118e
CHEMBL219327 83361 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 479 7 2 4 4.1 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)C1 10.1021/jm061118e
44419032 84557 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 8 2 5 4.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL222058 84557 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 8 2 5 4.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
16105840 84359 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 468 7 1 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(OCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221789 84359 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 468 7 1 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(OCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
10254576 84376 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 480 6 3 5 2.6 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CN)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221904 84376 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 480 6 3 5 2.6 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CN)CC2)c2ccccc12 10.1021/jm061118e
16105824 84270 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 549 5 2 5 3.5 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCN(C)CC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221251 84270 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 549 5 2 5 3.5 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCN(C)CC3)CC2)c2ccccc12 10.1021/jm061118e
16105892 141607 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 534 5 2 4 4.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCCCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL385108 141607 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 534 5 2 4 4.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCCCC3)CC2)c2ccccc12 10.1021/jm061118e
11452569 83201 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 408 5 2 3 4.7 O=C(Nc1ccc(S(=O)(=O)NC2CCCCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL218503 83201 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 408 5 2 3 4.7 O=C(Nc1ccc(S(=O)(=O)NC2CCCCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
3384970 161281 8 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 432 6 2 4 4.9 COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)cc1 10.1021/jm061118e
CHEMBL412116 161281 8 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 432 6 2 4 4.9 COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)cc1 10.1021/jm061118e
44419031 137702 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 467 7 2 5 4.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL375880 137702 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 467 7 2 5 4.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
10391077 137384 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 6 2 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(C(=O)Nc3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL375315 137384 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 6 2 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(C(=O)Nc3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105877 82824 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 3 5 2.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CO)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218036 82824 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 3 5 2.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CO)CC2)c2ccccc12 10.1021/jm061118e
16105844 82771 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 465 7 2 4 3.7 CCCC(=O)N1CC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)C1 10.1021/jm061118e
CHEMBL217979 82771 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 465 7 2 4 3.7 CCCC(=O)N1CC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)C1 10.1021/jm061118e
16105830 83398 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 564 11 2 5 4.8 CCN(CC)CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL219487 83398 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 564 11 2 5 4.8 CCN(CC)CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
11235229 83413 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 409 5 3 4 3.1 O=C(Nc1ccc(S(=O)(=O)NC2CCNCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL219588 83413 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 409 5 3 4 3.1 O=C(Nc1ccc(S(=O)(=O)NC2CCNCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
11541506 76516 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 575 9 2 5 5.7 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)C1 10.1021/jm050965z
CHEMBL205993 76516 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 575 9 2 5 5.7 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)C1 10.1021/jm050965z
16105893 83147 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 536 5 2 5 3.6 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCOCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218218 83147 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 536 5 2 5 3.6 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCOCC3)CC2)c2ccccc12 10.1021/jm061118e
16105803 84409 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 465 5 2 4 3.7 CC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221977 84409 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 465 5 2 4 3.7 CC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
11706579 139737 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 543 9 3 6 4.3 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)(C(=O)O)CC2)c1 10.1021/jm050965z
CHEMBL379834 139737 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 543 9 3 6 4.3 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)(C(=O)O)CC2)c1 10.1021/jm050965z
11533398 75986 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 499 8 2 5 4.9 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)CC2)c1 10.1021/jm050965z
CHEMBL205447 75986 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 499 8 2 5 4.9 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)CC2)c1 10.1021/jm050965z
16105876 137204 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 491 6 2 4 4.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL374979 137204 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 491 6 2 4 4.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CC3)CC2)c2ccccc12 10.1021/jm061118e
16105826 83176 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 578 9 2 6 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCN3CCOCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218366 83176 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 578 9 2 6 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCN3CCOCC3)CC2)c2ccccc12 10.1021/jm061118e
16105820 141633 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 7 3 4 4.3 CCCNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL385288 141633 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 7 3 4 4.3 CCCNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105821 83172 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 6 3 4 4.3 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)NC(C)C)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218350 83172 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 6 3 4 4.3 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)NC(C)C)CC2)c2ccccc12 10.1021/jm061118e
1099153 83142 10 None - 1 Human 5.1 pKi = 5.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 396 4 1 4 3.1 O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL218207 83142 10 None - 1 Human 5.1 pKi = 5.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 396 4 1 4 3.1 O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
16105882 141995 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 527 6 2 4 5.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)c3ccccc3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL387451 141995 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 527 6 2 4 5.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)c3ccccc3)CC2)c2ccccc12 10.1021/jm061118e
11685733 140202 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 589 9 2 5 6.1 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL380492 140202 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 589 9 2 5 6.1 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105804 83390 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 519 6 2 4 4.9 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL219433 83390 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 519 6 2 4 4.9 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
11329260 84239 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 487 6 2 5 3.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(C(=O)NC3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221021 84239 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 487 6 2 5 3.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(C(=O)NC3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
11530171 75970 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 338 6 1 3 3.8 CCNC(=O)C1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
CHEMBL205304 75970 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 338 6 1 3 3.8 CCNC(=O)C1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
11681610 140585 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 338 6 1 3 4.0 CCC(=O)NC1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
CHEMBL381354 140585 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 338 6 1 3 4.0 CCC(=O)NC1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z